The Impact of Cannabis Access Laws on Opioid Prescribing | Zendy

Benjamin J. McMichael | Zendy; Robert Horn | Zendy; W. Kip Viscusi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The Impact of Cannabis Access Laws on Opioid Prescribing

Author(s) -

Benjamin J. McMichael,

Robert Horn,

W. Kip Viscusi

Publication year - 2018

Publication title -

ssrn electronic journal

Language(s) - English

Resource type - Journals

ISSN - 1556-5068

DOI - 10.2139/ssrn.3266629

Subject(s) - cannabis , opioid , law , opioid abuse , business , political science , medicine , psychiatry , receptor

While recent research has shown that cannabis access laws can reduce the use of prescription opioids, the effect of these laws on opioid use is not well understood for all dimensions of use and for the general United States population. Analyzing a dataset of over 1.5 billion individual opioid prescriptions between 2011 and 2018, which were aggregated to the individual provider-year level, we find that recreational and medical cannabis access laws reduce the number of morphine milligram equivalents prescribed each year by 11.8 and 4.2 percent, respectively. These laws also reduce the total days’ supply of opioids prescribed, 180

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research